SCHEMBL21834285

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL21834236	0.91	SCN9A (0.45)	CYP2C9SCN9ACTSAELANEAKR1C3
	SCHEMBL21834335	0.88	CTSA (0.43)	CTSAELANEGRIN1GRIN2B
	SCHEMBL21834250	0.84	CYP2C9 (0.41)	CYP2C9SCN9ACTSAELANEAKR1C3
	SCHEMBL23243893	0.83	ELANE (0.42)	CYP2C9SCN9ACTSAELANEAKR1C3
	SCHEMBL21834283	0.81	CTSA (0.48)	SCN9ACTSA
	SCHEMBL21834276	0.80	CTSA (0.44)	CTSAELANE
	SCHEMBL21834268	0.80	CTSA (0.46)	CTSAELANE
	SCHEMBL21834312	0.79	CTSA (0.43)	CTSAELANEGRIN1GRIN2B
	SCHEMBL21834245	0.79	CTSA (0.41)	CTSAELANEGRIN1GRIN2B
	SCHEMBL21834307	0.79	CTSA (0.43)	CTSAELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.